UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes

Journal of Clinical Microbiology, 2011-11, Vol.49 (11), p.3983-3985

2011

Volltextzugriff (PDF)

High-Risk Human Papillomavirus (hrHPV) E6/E7 mRNA Testing by PreTect HPV-Proofer for Detection of Cervical High-Grade Intraepithelial Neoplasia and Cancer among hrHPV DNA-Positive Women with Normal Cytology

Journal of Clinical Microbiology, 2012-07, Vol.50 (7), p.2390-2396

2012

Volltextzugriff (PDF)

Penile cancer: epidemiology, pathogenesis and prevention

World journal of urology, 2009-04, Vol.27 (2), p.141, Article 141

2009

Volltextzugriff (PDF)

Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells

Gene therapy, 2007-02, Vol.14 (4), p.366-375

2007

Volltextzugriff (PDF)

High-risk HPV type-specific clearance rates in cervical screening

British journal of cancer, 2007-05, Vol.96 (9), p.1419-1424

2007

Volltextzugriff (PDF)

Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study

British journal of cancer, 2006-07, Vol.95 (1), p.96-101

2006

Volltextzugriff (PDF)

Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches

BMC infectious diseases, 2020-07, Vol.20 (1), p.1-482, Article 482

2020

Volltextzugriff (PDF)

Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study

British journal of cancer, 2006-12, Vol.95 (11), p.1593-1597

2006

Volltextzugriff (PDF)

Cervical cancer screening: on the way to a shift from cytology to full molecular screening

Annals of oncology, 2014-05, Vol.25 (5), p.927-935

2014

Volltextzugriff (PDF)

Methylation marker analysis of self‐sampled cervico‐vaginal lavage specimens to triage high‐risk HPV‐positive women for colposcopy

International journal of cancer, 2014-08, Vol.135 (4), p.880-886

2014

Volltextzugriff (PDF)

Comparison of the Clinical Performance of PapilloCheck Human Papillomavirus Detection with That of the GP5+/6+-PCR-Enzyme Immunoassay in Population-Based Cervical Screening

Journal of Clinical Microbiology, 2010-03, Vol.48 (3), p.797-801

2010

Volltextzugriff (PDF)

The causal relation between human papillomavirus and cervical cancer

Journal of clinical pathology, 2002-04, Vol.55 (4), p.244-265

2002

Volltextzugriff (PDF)

The Aptima HPV Assay Fulfills the Cross-Sectional Clinical and Reproducibility Criteria of International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening

Journal of Clinical Microbiology, 2013-11, Vol.51 (11), p.3653-3657

2013

Volltextzugriff (PDF)

Clinical Validation of the Abbott RealTime High Risk HPV Assay According to the Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Screening

Journal of Clinical Microbiology, 2013-07, Vol.51 (7), p.2409-2410

2013

Volltextzugriff (PDF)

CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature

Annals of oncology, 2004-07, Vol.15 (7), p.1097-1108

2004

Volltextzugriff (PDF)

Cross-Sectional Comparison of an Automated Hybrid Capture 2 Assay and the Consensus GP5+/6+ PCR Method in a Population-Based Cervical Screening Program

Journal of Clinical Microbiology, 2006-10, Vol.44 (10), p.3680-3685

2006

Volltextzugriff (PDF)

Activity-based differentiation of pathologists’ workload in surgical pathology

Virchows Archiv : an international journal of pathology, 2009-06, Vol.454 (6), p.623-628

2009

Volltextzugriff (PDF)

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study

British journal of cancer, 2014-03, Vol.110 (6), p.1579-1586

2014

Volltextzugriff (PDF)

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

Clinical microbiology and infection, 2015-09, Vol.21 (9), p.817-826

2015

Volltextzugriff (PDF)

Clusterin: a protective mediator for ischemic cardiomyocytes?

American journal of physiology. Heart and circulatory physiology, 2005-11, Vol.289 (5), p.H2193-H2202

2005

Volltextzugriff (PDF)

Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix

The Journal of pathology, 2006-06, Vol.209 (2), p.220-230

2006

Volltextzugriff (PDF)

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis

British journal of cancer, 2007-11, Vol.97 (10), p.1457-1464

2007

Volltextzugriff (PDF)

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

British journal of cancer, 2008-02, Vol.98 (3), p.646-651

2008

Volltextzugriff (PDF)

Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders

British journal of dermatology (1951), 2009-07, Vol.161 (1), p.121-127

2009

Volltextzugriff (PDF)

HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme

Preventive medicine, 2019-02, Vol.119, p.108-117

2019

Volltextzugriff (PDF)

1 – 25 von 2.172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.019)
Mit Volltextzugriff
(1.916)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes

High-Risk Human Papillomavirus (hrHPV) E6/E7 mRNA Testing by PreTect HPV-Proofer for Detection of Cervical High-Grade Intraepithelial Neoplasia and Cancer among hrHPV DNA-Positive Women with Normal Cytology

Penile cancer: epidemiology, pathogenesis and prevention

Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells

High-risk HPV type-specific clearance rates in cervical screening

Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study

Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches

Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study

Cervical cancer screening: on the way to a shift from cytology to full molecular screening

Methylation marker analysis of self‐sampled cervico‐vaginal lavage specimens to triage high‐risk HPV‐positive women for colposcopy

Comparison of the Clinical Performance of PapilloCheck Human Papillomavirus Detection with That of the GP5+/6+-PCR-Enzyme Immunoassay in Population-Based Cervical Screening

The causal relation between human papillomavirus and cervical cancer

The Aptima HPV Assay Fulfills the Cross-Sectional Clinical and Reproducibility Criteria of International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening

Clinical Validation of the Abbott RealTime High Risk HPV Assay According to the Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Screening

CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature

Cross-Sectional Comparison of an Automated Hybrid Capture 2 Assay and the Consensus GP5+/6+ PCR Method in a Population-Based Cervical Screening Program

Activity-based differentiation of pathologists’ workload in surgical pathology

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

Clusterin: a protective mediator for ischemic cardiomyocytes?

Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders

HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme

Suchergebnisse filtern